Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Development of a Small Molecule Screen for Coronavirus (CoV-2) Frameshifting Modulators Using Yeast
EF 2021-22
Résumé
Fighting the global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (CoV-2) requires broader strategies than immunity-based solutions; antivirals resistant to future CoV-2 strains are necessary, especially for immunocompromised populations. A mechanism called frameshifting is used by CoV-2 for protein production and is specific to viruses (therefore it is not used by human cells). Frameshifting is necessary for viral replication and infection of the host, and is common among many RNA viruses. Current evidence suggests that the CoV-2 structure stimulating the frameshifting mechanism and the mechanism itself are consistent between families of coronaviruses, indicating that antivirals targeting frameshifting would not lose efficacy against emerging viral strains. Frameshifting is finely tuned to produce specific amounts of protein required for viral infection. Disrupting frameshifting to modulate the rate of protein output will result in inhibition of viral infection. This project aims to identify small molecules that modulate frameshifting in CoV-2 using a novel yeast growth assay platform to allow for the rapid identification of potential antiviral compounds. The project will re-purpose yeast assays that have been previously used in our facilities to allow for simple setup and optimization. Once candidate compounds have been identified, they will be screened in a mammalian system. Compounds that emerge as candidates from this screen will then be tested for their ability to inhibit the reproduction of CoV-2. The development of this methodology and screen will create a system able to rapidly identify specific inhibitors of conserved and key viral mechanisms, which is crucial for fighting current and future viral outbreaks.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466641
Name
Osborne Tessa S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of a Small Molecule Screen for Coronavirus (CoV-2) Frameshifting Modulators Using Yeast
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Coronavirus; Frameshifting; Sars-Cov-2; Small Molecule; Translation; Viral Inhibition
Abstract
Fighting the global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (CoV-2) requires broader strategies than immunity-based solutions; antivirals resistant to future CoV-2 strains are necessary, especially for immunocompromised populations. A mechanism called frameshifting is used by CoV-2 for protein production and is specific to viruses (therefore it is not used by human cells). Frameshifting is necessary for viral replication and infection of the host, and is common among many RNA viruses. Current evidence suggests that the CoV-2 structure stimulating the frameshifting mechanism and the mechanism itself are consistent between families of coronaviruses, indicating that antivirals targeting frameshifting would not lose efficacy against emerging viral strains. Frameshifting is finely tuned to produce specific amounts of protein required for viral infection. Disrupting frameshifting to modulate the rate of protein output will result in inhibition of viral infection. This project aims to identify small molecules that modulate frameshifting in CoV-2 using a novel yeast growth assay platform to allow for the rapid identification of potential antiviral compounds. The project will re-purpose yeast assays that have been previously used in our facilities to allow for simple setup and optimization. Once candidate compounds have been identified, they will be screened in a mammalian system. Compounds that emerge as candidates from this screen will then be tested for their ability to inhibit the reproduction of CoV-2. The development of this methodology and screen will create a system able to rapidly identify specific inhibitors of conserved and key viral mechanisms, which is crucial for fighting current and future viral outbreaks.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Osborne, Tessa S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~